How much will the Breast Lesion Localization Methods industry be worth in the Future????
The global breast
lesion localization methods market
size is expected to reach USD 1.58
billion by 2025, according to a new report by Grand View Research, Inc. It
is projected to witness a CAGR of 13.3% during the forecast period. Growing
number of government and non-government reimbursement policies for the breast
cancer diagnostics, biopsy, examination, and other medical procedures are
estimated to increase the adoption of breast lesion localization methods.
Moreover, high demand for better healthcare infrastructure and facilities due
to rising prevalence of the target disease among women is expected to fuel the
market growth.
The most common concern for the governments of
all Covid-19 hit nations is the excruciating need to screen for and test large
numbers of patients for possible Sars-Cov-2 infection. As a result, most of
them are facing major shortages in the supply for diagnostic kits to test for
the virus. Diagnostics virology entities are under immense pressure to provide
reliable testing kits, and there is a surge in demand for in-vitro or
point-of-care testing capacities by labs across a large number of countries.
The report will account for Covid19 as a key market contributor.
It is more prevalent in women above
the age of 50 years. Although it is majorly occurring in women, the male
population has one in eight chances of being diagnosed with the target cancer.
According to the WHO, almost 6.5% of all cancer-related deaths worldwide are
caused by breast cancer. Increasing awareness level about breast cancer
screening is expected to further enhance the market growth. For instance, in
U.S., the Centre of Disease Control and Prevention’s National Breast and
Cervical Cancer Early Detection Program (NBCCEDP) provides free access to
timely breast and cervical diagnostic and screening services to the needy
patients.
These screening programs include
high-quality mammogram diagnosis, which involves breast X-rays, biopsies (if
required), and an analytical judgment. Key companies, such as C.R. Bard, Inc.;
Cianna Medical, Inc.; and Cook Medical, Inc. focus on business expansion in
developing regions in an attempt to increase their market share. They are also
adopting several other strategies, such as M&A and product launch. For
instance, in October 2018, Cianna Medical, Inc. signed a merger agreement with
Merit Medical Systems, Inc., in which the latter will provide clinical support
for R&D to Cianna Medical, Inc. for commercializing new technologies in the
market.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
The global breast lesion
localization methods market was valued at USD 580.7 million in 2017 and is
expected to grow lucratively over the forecast period
·
Wire-guided localization
segment held the largest market share of 35.9% in 2017 owing to the presence of
wide range of products and high adoption of this technique among end-users
·
Radioisotope localization is
expected to witness significant growth over the forecast period as it is an
effective, safe, and widely used procedure for preoperative localization of
non-palpable, suspicious breast lesions
·
North America led the market
with revenue of USD 209.96 million in 2017. The presence of key manufacturers
in U.S., established healthcare infrastructure, and high adoption of
localization devices are the factors responsible for its largest share
·
Asia Pacific is expected to
witness the fastest CAGR of 15.3% during the forecast period due to increasing
demand for breast conserving surgery.
The
global breast lesion localization methods market size was valued at USD 580.7
Million in 2017 and is projected to expand further at a CAGR of 13.3% during
the forecast period. Breast cancer is the most prominent and invasive cancers;
thus, increasing prevalence of it among women is expected to drive the market
growth.
According
to the Breast Cancer Organization, it was estimated that in 2018, 266,120 new
cases of invasive and 63,960 cases of non-invasive breast cancer would be
diagnosed. Rising number of government and non-government reimbursement
policies for breast cancer diagnostics, biopsy, and other related medical
procedures is estimated to boost the adoption of breast lesion localization
methods.
Rising
demand for better healthcare infrastructure and facilities and increasing
awareness level about breast cancer screening are also expected to boost the
market growth. For instance, national breast cancer screening program in
Australia called the Breast Screen Australia, which provides free mammogram
test services every two years for women aged between 50 and 74. Developing
regions, such as India and China, are also spreading awareness about early
diagnosis.
In addition,
introduction of technologically advanced products on the grounds of accuracy,
safety, and cost-effectiveness is considered as the high impact-rendering
factor for the breast lesion localization methods market. Companies, such as
Endomagnetics and Cianna Inc. have developed new range of techniques
respectively working on magnetic and electroradar guidance for localization of
breast lesions. For instance, SAVI SCOUT localization technology of Cianna
Medical, Inc. has performed over 50,000-breast tumor localization in over 375
hospitals across U.S.
Browse Press
Release of this report:
Grand View Research has segmented the
global breast lesion localization methods market on the basis of type:
Breast Lesion Localization Methods Type Outlook
(Revenue, USD Million, 2014 - 2025)
·
Wire Guided
·
Radioisotope
o Radio Guided Occult-Lesion Localization (ROLL)
o Radioactive-Seed Localization (RSL)
o Others
·
Magnetic Tracer
·
Others
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment